Literature DB >> 9717844

Estrogen receptor, a common interaction partner for a subset of nuclear receptors.

S K Lee1, H S Choi, M R Song, M O Lee, J W Lee.   

Abstract

Nuclear receptors regulate transcription by binding to specific DNA response elements as homodimers or heterodimers. Herein, the yeast and mammalian two-hybrid tests as well as glutathione-S-transferase pull-down assays were exploited to demonstrate that estrogen receptor (ER) directly binds to a subset of nuclear receptors through protein-protein interactions between ligand-binding domains. These receptors include hepatocyte nuclear factor 4, thyroid hormone receptor (TR), retinoic acid receptor (RAR), ERbeta, and retinoid X receptor (RXR). In yeast cells, a LexA fusion protein to the human ER ligand-binding domain (LexA/ER-LBD) was an inert transactivator of a LacZ reporter gene controlled by upstream LexA-binding sites. However, LexA/ER-LBD differentially modulated the LacZ reporter gene expression when coexpressed with native TRs, RARs, or RXRs. Similarly, cotransfection of these receptors in CV1 cells up- or down-regulated transactivations by ER. From these results, we propose that ER is a common interaction partner for a subset of receptors, and these interactions should mediate novel signaling pathways in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9717844     DOI: 10.1210/mend.12.8.0146

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  18 in total

1.  Activating signal cointegrator 1, a novel transcription coactivator of nuclear receptors, and its cytosolic localization under conditions of serum deprivation.

Authors:  H J Kim; J Y Yi; H S Sung; D D Moore; B H Jhun; Y C Lee; J W Lee
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Differential modulation of transcriptional activity of oestrogen receptors by direct protein-protein interactions with retinoid receptors.

Authors:  M R Song; S K Lee; Y W Seo; H S Choi; J W Lee; M O Lee
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

Review 3.  Nuclear receptor crosstalk - defining the mechanisms for therapeutic innovation.

Authors:  Karolien De Bosscher; Sofie J Desmet; Dorien Clarisse; Eva Estébanez-Perpiña; Luc Brunsveld
Journal:  Nat Rev Endocrinol       Date:  2020-04-17       Impact factor: 43.330

4.  From Influenza Virus Infections to Lupus: Synchronous Estrogen Receptor α and RNA Polymerase II Binding Within the Immunoglobulin Heavy Chain Locus.

Authors:  Bart G Jones; Robert E Sealy; Rhiannon R Penkert; Sherri L Surman; Barbara K Birshtein; Beisi Xu; Geoffrey Neale; Robert W Maul; Patricia J Gearhart; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2020-02-27       Impact factor: 2.257

5.  In Vivo Hepatic Enhancer Elements in the Human ABCG2 Locus.

Authors:  Rachel J Eclov; Mee J Kim; Robin P Smith; Xiaomin Liang; Nadav Ahituv; Deanna L Kroetz
Journal:  Drug Metab Dispos       Date:  2016-11-17       Impact factor: 3.922

Review 6.  Antiestrogens--tamoxifen, SERMs and beyond.

Authors:  K Dhingra
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

7.  Early-onset breast disease: case of a Grave condition with a favorable prognosis.

Authors:  James E Siegler; Steven D Jones; Emad Kandil
Journal:  Int J Clin Exp Med       Date:  2012-06-15

8.  The effect of estrogen compounds on human embryoid bodies.

Authors:  Hoon Kim; Yoon Young Kim; Seung-Yup Ku; Seok Hyun Kim; Young Min Choi; Shin Yong Moon
Journal:  Reprod Sci       Date:  2012-11-26       Impact factor: 3.060

9.  The Fox and the Rabbits-Environmental Variables and Population Genetics (1) Replication Problems in Association Studies and the Untapped Power of GWAS (2) Vitamin A Deficiency, Herpes Simplex Reactivation and Other Causes of Alzheimer's Disease.

Authors:  C J Carter
Journal:  ISRN Neurol       Date:  2011-07-12

10.  Genome wide prediction of HNF4alpha functional binding sites by the use of local and global sequence context.

Authors:  Alexander E Kel; Monika Niehof; Volker Matys; Rüdiger Zemlin; Jürgen Borlak
Journal:  Genome Biol       Date:  2008-02-21       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.